Cantor Fitzgerald Reaffirms “Overweight” Rating for Maplebear (NASDAQ:CART)
Maplebear (NASDAQ:CART – Get Free Report)‘s stock had its “overweight” rating reaffirmed by research analysts at Cantor Fitzgerald in a report issued on Monday, Benzinga reports. They currently have a $45.00 price objective on the stock. Cantor Fitzgerald’s target price would indicate a potential upside of 12.28% from the stock’s current price. Other research analysts […]
Lilium (NASDAQ:LILM) Stock Rating Reaffirmed by Cantor Fitzgerald
Lilium (NASDAQ:LILM – Get Free Report)‘s stock had its “overweight” rating reiterated by Cantor Fitzgerald in a report issued on Monday, Benzinga reports. They currently have a $2.00 target price on the stock. Cantor Fitzgerald’s target price indicates a potential upside of 171.00% from the company’s current price. Separately, Canaccord Genuity Group reiterated a “buy” […]
Elevance Health (NYSE:ELV) Earns Overweight Rating from Cantor Fitzgerald
Cantor Fitzgerald reaffirmed their overweight rating on shares of Elevance Health (NYSE:ELV – Free Report) in a report released on Friday, Benzinga reports. Cantor Fitzgerald currently has a $600.00 price target on the stock. Several other brokerages also recently weighed in on ELV. StockNews.com downgraded shares of Elevance Health from a strong-buy rating to a […]
LifeMD (NASDAQ:LFMD) Stock Rating Reaffirmed by Cantor Fitzgerald
Cantor Fitzgerald reaffirmed their overweight rating on shares of LifeMD (NASDAQ:LFMD – Free Report) in a research report released on Friday, Benzinga reports. The firm currently has a $15.00 target price on the stock. Other analysts have also recently issued research reports about the company. B. Riley started coverage on LifeMD in a research report […]
last updated on 25 Sep 09:12